http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102186270-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2019-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102186270-B1 |
| titleOfInvention | melatonin as therapeutic drug to inhibit activity of Vibrio vulnificus in vivo and in vitro infected host model |
| abstract | The present invention relates to a composition for preventing or treating sepsis or septic shock comprising melatonin as an active ingredient. Melatonin of the present invention has the effect of inhibiting apoptosis of small intestinal epithelial cells infected with Vibrio bacteria, and has the effect of restoring the inhibition of mucin production of intestinal epithelial cells infected with Vibrio There is an effect that can be usefully used as a composition for. |
| priorityDate | 2019-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 179.